Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jean-Marie Péron
Observed name:
Jean-Marie Peron
Institutions:
Centre Hospitalier Universitaire de Toulouse,
Hôpital Rangueil
Observed institutions:
Université Toulouse III - Paul Sabatier,
Centre Hospitalier Universitaire de Toulouse,
Hôpital Rangueil,
Hôpital Purpan,
Hôpital Paule de Viguier,
Hôpital de La Grave
show all 6
ORCID:
0000-0002-0510-8577
Observed ORCID:
0000-0002-0510-8577
OpenAlex ID:
A5105937339
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
2018
·
Nathalie Ganne-Carrié
, Cendrine Chaffaut
, et al.
·
Journal of Hepatology
·
147
PDF
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
2016
·
Ghassan K. Abou-Alfa
, Oscar Puig
, et al.
·
Journal of Hepatology
·
147
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis
2022
·
Pierre Nahon
, Jessica Bamba-Funck
, et al.
·
Journal of Hepatology
·
86
PDF
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
2025
·
Jean-Paul Cervoni
, Delphine Weil
, et al.
·
The Lancet. Gastroenterology & hepatology
·
40
Hepatitis D Virus Infection Markedly Increases the Risk of Hepatocellular Carcinoma in Patients With Viral B Cirrhosis
2024
·
Dominique Roulot
, Richard Layese
, et al.
·
Clinical Gastroenterology and Hepatology
·
13
PDF
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma
2026
·
Jean-Charles Nault
, Claudia Campani
, et al.
·
Journal of Hepatology
·
8
PDF
Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinoma
2025
·
Anaïs Lopez
, Alexia Paturel
, et al.
·
PLoS ONE
·
3
PDF
Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC).
2024
·
Philippe Merle
, Jean-Marie Peron
, et al.
·
Journal of Clinical Oncology
·
3
Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma
2026
·
Anne-Victoire Odent
, Claudia Campani
, et al.
·
JHEP Reports
·
2
PDF
Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data
2026
·
Claudia Campani
, Ju Hyun Shim
, et al.
·
Clinical Cancer Research
·
2
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study
2025
·
François Villeret
, Mohamed Bouattour
, et al.
·
Liver Cancer
·
1
PDF
Show more works
View as search
Works count:
11
Citation count:
452
H-index:
6
I10-index:
5
Year
Topic
Type